News

Emerging Healthcare Solutions has reported the execution of an exclusive option agreement with ThromboVision, which has developed and patented T-Guide, a new diagnostic test to assist medical professionals

Soligenix (formerly known as DOR BioPharma) has reported the publication of an article in the January 2010 edition of Infection and Immunity, detailing the characteristics of several immunodominant

Brainware has reported that bioMerieux has selected the company’s Distiller solution to automate its accounts payable process. bioMerieux maintains a global presence across 150 countries and is required

Amicas has entered into a merger agreement to be acquired by an affiliate of Thoma Bravo, in a transaction valued at approximately $217m. The Amicas board of directors

The FDA has granted tentative approval to Glenmark Generics US (GGI), a subsidiary of Glenmark Generics, for Pramipexole Dihydrochloride tablets, the generic version of Boehringer Ingelheim’s Mirapex tablets.

Ohm Laboratories (Ohm), a wholly-owed subsidiary of Ranbaxy Laboratories, has received a warning letter from the FDA for its liquid manufacturing facility located in Gloversville, New York. The

Merck KGaA (Merck) has sufficient funds and is planning to go for acquisitions in pharmaceuticals and chemical industries, reported Reuters, quoting a German newspaper. Karl-Ludwig Kley, chief executive

Sinovac Biotech (Sinovac) has filed an application with China’s State Food and Drug Administration (SFDA) to commence a human clinical trial for its vaccine against human enterovirus 71

Compugen has reported the discovery and experimental validation of CGEN-671, a new drug target for multiple epithelial tumors. CGEN-671 is a membrane splice variant of CD55, a known